Site-randomised trial of a multilevel digital intervention to reduce maternal morbidity and mortality: a study protocol.
Sydney S Kelpin, Claire E Margerison, Athena S McKay...
https://pubmed.ncbi.nlm.nih.gov/41423300/Actively Recruiting
Led by Michigan State University · Updated on 2026-07-24
500
Participants Needed
8
Research Sites
52 weeks
Total Duration
Researchers are evaluating the Michigan Healthy Mom MI MOM app to determine if it improves pregnancy and postpartum health among pregnant women, their supporters, and healthcare providers. The study uses a site-randomized design to compare outcomes between those using the MI MOM app and those receiving treatment as usual. The research also aims to assess whether the app can reduce disparities in pregnancy and postpartum health between racial and geographic groups. Participants in the MI MOM app group will receive interactive app content and regular text messages with information designed to enhance awareness of warning signs, promote self-advocacy, and improve health during pregnancy and postpartum. They may also invite up to three close friends or family members to receive supportive text messages. Additionally, participants have the option to contact a community health worker through online chat. The other group will receive standard care without the app intervention. During the study, participants will answer questions about their pregnancy health. Researchers will collect vital records and Medicaid claims related to pregnancy for all participants. The main outcomes measured include total pregnancy-associated morbidity and mortality up to one year postpartum and a composite index of maternal morbidity and mortality risk factors assessed at multiple time points. The study is expected to run from July 2026 through December 2031.
CONDITIONS
Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
S
Steven J Ondersma, PhD
C
Claire E Margerison, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Michigan State University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | MI MOM App (Digital Support) | Treatment as Usual |
|---|---|---|
| What it is | A digital health intervention providing pregnancy-related education, symptom monitoring, and live chat support with community healthcare workers via the MI MOM smartphone app. | Routine prenatal and postpartum care as provided according to Medicaid coverage and standard clinical practice, without access to the MI MOM App. |
| Role in the trial | Interventional arm. Receives digital support to test if it reduces maternal morbidity and mortality risk compared to usual care. | Comparator arm. Receives usual care for comparison against the digital intervention. |
| Primary use | To improve pregnancy outcomes by educating patients, raising awareness of maternal warning signs, supporting self-advocacy, and connecting participants to health services. | To provide routine prenatal care, maternal monitoring, and access to standard Medicaid-covered services without additional digital tools or support. |
| How it is given or performed | Participants use a smartphone app with interactive content, receive regular text messages, and have live chat access to community health workers. Support persons can also receive information and participate. | Participants attend regular prenatal and postpartum visits and follow standard Medicaid-covered care, without receiving digital education, live chat, or app-based support. |
| Evidence status | Effectiveness for reducing pregnancy-related complications and mortality is under evaluation; no results are posted yet for this population. | Represents the observed outcomes for routine prenatal care in this population; outcome measurement serves as trial benchmark. |
| Important limitations | No published outcome data yet; digital engagement and benefit depend on technology access and sustained participant use over pregnancy and postpartum periods. | Outcomes may vary due to differences in service access, provider practices, and patient health literacy; standard care does not include systematic digital support. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - From enrollment through 1 year postpartum
Participants in the MI MOM app group receive app content and text messages aimed at improving pregnancy health, with optional support from a community health worker. The comparison group receives usual care. All participants answer pregnancy health questions and have related records collected.
Regular assessments at 6 weeks post-baseline, 35 weeks of pregnancy, 6 weeks postpartum, 6 months postpartum, and 1 year postpartum
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Sydney S Kelpin, Claire E Margerison, Athena S McKay...
https://pubmed.ncbi.nlm.nih.gov/41423300/Sydney S Kelpin, Claire E Margerison, Athena S McKay...
https://pubmed.ncbi.nlm.nih.gov/41282939/Michigan State University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor